TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CTOR

Citius Oncology, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

1.00$ +6.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Citius Oncology, Inc. (CTOR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 112 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CTOR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
48 48 49 50 84 90 91 92 101 110 101 112
7.7 7.7 8.9 10 11 17 18 18 28 37 29 43
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 7.3 2.6 17
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 7.3 2.6 17
4.0 1.1 0.7
8.3 14 15 17 22 23 23 23
40 73 73 73 73 73 73 71 69
22 25 29 33 38 49 56 59 56 52 65 72
21 24 28 31 33 43 50 53 49 45 59 59
1.5 1.7
1.3 0.2 0.5 3.7 5.9 7.7 8.7 13 10 8.9 7.3
3.8 3.8 3.8 3.8 3.8 3.8 3.8 10
26 23 20 17 46 41 36 32 45 58 35 40
-18 -23 -28 -32 -39 -46 -54 -59 -64 -70 -96 -105
89 89 67 67 72 72 72 72 81 87 100 108

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?